[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"aphthus-ulcer\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:aphthus-ulcer":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100586069","phase-2-oxygenated-gel-therapy-in-the-management-of-oral-aphthous-ulcers-100586069",false,"NCT06910579","Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers","Efficacy of Oxygenated Gel Therapy in the Management of Oral Aphthous Ulcers: A Randomized Controlled Clinical Trial","Inclusion Criteria:\n\n* Clinically diagnosed patients with chronic aphthous stomatitis measuring ≤6 mm in size in the oral cavity and who gave written consent for participation.\n* Only single ulcers were considered for the study.\n* Systemically healthy patients.\n\nExclusion Criteria:\n\n* The study excluded patients with a history of associated systemic disease.\n* Cases of chronic aphthous stomatitis (major), lesions of herpetic form, numerous aphthae, and smoking.\n* Patients with a history of hypersensitivity to the used agents.\n* Pregnancy and lactation","ALL",{"count":18,"type":19},30,"ESTIMATED","INTERVENTIONAL",[22,23],"PHASE2","PHASE3","Interventions of both groups:\n\nOxygenated gel Group: 15 patients who used oxygenated gel (Blue®m, Wijhe, Netherlands) were trained by the co-investigator (A.H) through real demonstration for topical application of the gel on aphthous ulcers, which entails the application of 1-2 ml of oxygenated gel directly to the ulcer two times per day and this was repeated for 7 days.\n\nTriamcinolone acetonide Group: 15 patients were treated with Kenalog in orabase (Triamcinolone acetonide 0.1% oral paste 5g), four times (i.e., at 8 am, 12 noon, 4 pm, and 8 pm) a day for 7 days at intervention group.\n\nPatients in both groups were reexamined after treatment at different intervals (day 3, day 5, day 7, and day 10).",[26],"Aphthus Ulcer","RECRUITING","2025-09-16",{"date":30,"type":31},"2025-09-18","ACTUAL",{"date":33,"type":31},"2025-03-15",{"date":35,"type":19},"2026-04-12",{"name":37,"class":38},"British University In Egypt","OTHER"]